ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

PEDVAXHIB
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

PEDVAXHIB Rx

Generic Name and Formulations:
Haemophilus b conjugate 7.5mcg (meningococcal protein conjugate 250mcg); per 0.5mL; IM inj.

Company:
Merck & Co., Inc.

Therapeutic Use:

Indications for PEDVAXHIB:

Immunization of children against H. influenzae type b.

Children:

<2 months: not recommended. 2 and 4 months: 0.5mL lM. Children vaccinated (with 2 dose regimen) before 12 months should receive booster at 12 months (but not <2 months after previous shot). Previously unvaccinated children, 15–71 months: 0.5mL lM once.

Contraindications:

Aluminum allergy.

Warnings/Precautions:

Immunodeficiency. Delay administration in febrile or active infection. Have epinephrine inj (1:1000) available. Protection begins several days after injection. Pregnancy (Cat. C): not recommended.

Pharmacological Class:

Hib (PRP-OMP).

Adverse Reactions:

Local reactions, fever.

How Supplied:

Single-dose vials (w. diluent)—10

Sign Up for Free e-Newsletters

CME Focus